Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices

B Griffiths, M Mosca, C Gordon - Best practice & research Clinical …, 2005 - Elsevier
The assessment of disease activity in systemic lupus erythematosus (SLE) is a task faced by
clinicians in every day care, but it is also required for clinical research and in randomised …

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

C Gordon, MB Amissah-Arthur, M Gayed… - …, 2018 - academic.oup.com
Caroline Gordon1, 2, 3, Maame-Boatemaa Amissah-Arthur1, Mary Gayed1, 3, Sue Brown4,
Ian N. Bruce5, 6, David D'Cruz7, Benjamin Empson8, Bridget Griffiths9, David Jayne10, 11 …

BSR and BHPR guideline for the treatment of systemic sclerosis

CP Denton, M Hughes, N Gak, J Vila, MH Buch… - …, 2016 - academic.oup.com
Christopher P. Denton1, Michael Hughes2, Nataliya Gak1, Josephine Vila3, Maya H. Buch4,
Kuntal Chakravarty1, Kim Fligelstone1, Luke L. Gompels5, Bridget Griffiths3, Ariane L …

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

D Khanna, CJF Lin, DE Furst, J Goldin… - The Lancet …, 2020 - thelancet.com
Background A phase 2 trial of tocilizumab showed preliminary evidence of efficacy in
systemic sclerosis. We assessed skin fibrosis and systemic sclerosis-associated interstitial …

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial

JM Van Laar, D Farge, JK Sont, K Naraghi… - Jama, 2014 - jamanetwork.com
Importance High-dose immunosuppressive therapy and autologous hematopoietic stem cell
transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small …

Issues in cross‐cultural validity: Example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire

AA Küçükdeveci, H Sahin, S Ataman… - Arthritis Care & …, 2004 - Wiley Online Library
Objective Guidelines have been established for cross‐cultural adaptation of outcome
measures. However, invariance across cultures must also be demonstrated through analysis …

Development and validation of a disease‐specific health‐related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus

K McElhone, J Abbott, J Shelmerdine… - Arthritis Care & …, 2007 - Wiley Online Library
Objective To develop and validate a disease‐specific health‐related quality of life (HRQOL)
instrument for adults with systemic lupus erythematosus (SLE). Methods The work consisted …

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

AM Hoffmann-Vold, TM Maher, EE Philpot… - The Lancet …, 2020 - thelancet.com
Background Systemic sclerosis-associated interstitial lung disease (ILD) carries a high
mortality risk; expert guidance is required to aid early recognition and treatment. We aimed …

The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large …

CS Yee, VT Farewell, DA Isenberg, B Griffiths… - …, 2011 - academic.oup.com
Objectives. To examine SLEDAI-2000 cut-off scores for definition of active SLE and to
determine the sensitivity to change of SLEDAI-2000 for the assessment of SLE disease …

Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by …

K Bruynesteyn, D van der Heijde… - … : Official Journal of …, 2002 - Wiley Online Library
Objective. To assess the minimal clinically impor-tant difference (MCID) in joint damage on
hand and foot radiographs of patients with early rheumatoid arthritis (RA) as assessed with …